APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-driven Peptide Drug Discovery Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global AI-driven Peptide Drug Discovery Platform Market Analysis and Forecast 2026-2032

5 June 2026257 pages

Choose your research edition.

Industry ResearchAI-driven Peptide Drug Discovery Platform Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-driven Peptide Drug Discovery Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI-driven Peptide Drug Discovery Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-driven Peptide Drug Discovery Platform Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-driven Peptide Drug Discovery Platform Market Analysis and Forecast 2026-2032257 pages · $4,950 USD

Market perspective

The global AI-driven Peptide Drug Discovery Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for AI-driven Peptide Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for AI-driven Peptide Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for AI-driven Peptide Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for AI-driven Peptide Drug Discovery Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of AI-driven Peptide Drug Discovery Platform include Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI and Insilico Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for AI-driven Peptide Drug Discovery Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of AI-driven Peptide Drug Discovery Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for AI-driven Peptide Drug Discovery Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the AI-driven Peptide Drug Discovery Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global AI-driven Peptide Drug Discovery Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for AI-driven Peptide Drug Discovery Platform revenue, projected growth trends, production technology, application and end-user industry.

AI-driven Peptide Drug Discovery Platform Segment by Company

Peptilogics

Pepticom Ltd

Menten AI

GUBRA

Creative Peptides

Exscalate

Generate Biomedicines

Receptor.AI

Insilico Medicine

Schrödinger

BenevolentAI

Evotec

PeptiFinder

Xtalpi

Sun Novo

Zonsen Peplib Biotech

Tide Tron Biotech

AI-driven Peptide Drug Discovery Platform Segment by Type

Design and Generation Platform

Screening and Optimization Platform

Data-driven Platform

Others

AI-driven Peptide Drug Discovery Platform Segment by Application

Scientific Research

Pharmaceuticals

AI-driven Peptide Drug Discovery Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-driven Peptide Drug Discovery Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-driven Peptide Drug Discovery Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-driven Peptide Drug Discovery Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of AI-driven Peptide Drug Discovery Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of AI-driven Peptide Drug Discovery Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-driven Peptide Drug Discovery Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Design and Generation Platform Major Player Table 3. Screening and Optimization Platform Major Player Table 4. Data-driven Platform Major Player Table 5. Others Major Player Table 6. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Scientific Research Major Player Table 8. Pharmaceuticals Major Player Table 9. AI-driven Peptide Drug Discovery Platform Industry Trends Table 10. AI-driven Peptide Drug Discovery Platform Industry Drivers Table 11. AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges Table 12. AI-driven Peptide Drug Discovery Platform Industry Restraints Table 13. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026) & (US$ Million) Table 15. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2021-2026) Table 16. Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2027-2032) & (US$ Million) Table 17. Global AI-driven Peptide Drug Discovery Platform Market Share by Region (2027-2032) Table 18. Global AI-driven Peptide Drug Discovery Platform Revenue by Players (US$ Million) & (2021-2026) Table 19. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Players (2021-2026) Table 20. Global AI-driven Peptide Drug Discovery Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global AI-driven Peptide Drug Discovery Platform Key Players Headquarters & Area Served Table 22. Global AI-driven Peptide Drug Discovery Platform Players, Product Type & Application Table 23. Global AI-driven Peptide Drug Discovery Platform Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global AI-driven Peptide Drug Discovery Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global AI-driven Peptide Drug Discovery Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 28. Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 29. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2021-2026) Table 30. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2027-2032) Table 31. Global AI-driven Peptide Drug Discovery Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 33. Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 34. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021-2026) Table 35. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2027-2032) Table 36. Peptilogics Company Information Table 37. Peptilogics Business Overview Table 38. Peptilogics AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio Table 40. Peptilogics Recent Development Table 41. Pepticom Ltd Company Information Table 42. Pepticom Ltd Business Overview Table 43. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio Table 45. Pepticom Ltd Recent Development Table 46. Menten AI Company Information Table 47. Menten AI Business Overview Table 48. Menten AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 50. Menten AI Recent Development Table 51. GUBRA Company Information Table 52. GUBRA Business Overview Table 53. GUBRA AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio Table 55. GUBRA Recent Development Table 56. Creative Peptides Company Information Table 57. Creative Peptides Business Overview Table 58. Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio Table 60. Creative Peptides Recent Development Table 61. Exscalate Company Information Table 62. Exscalate Business Overview Table 63. Exscalate AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio Table 65. Exscalate Recent Development Table 66. Generate Biomedicines Company Information Table 67. Generate Biomedicines Business Overview Table 68. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio Table 70. Generate Biomedicines Recent Development Table 71. Receptor.AI Company Information Table 72. Receptor.AI Business Overview Table 73. Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 75. Receptor.AI Recent Development Table 76. Insilico Medicine Company Information Table 77. Insilico Medicine Business Overview Table 78. Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio Table 80. Insilico Medicine Recent Development Table 81. Schrödinger Company Information Table 82. Schrödinger Business Overview Table 83. Schrödinger AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio Table 85. Schrödinger Recent Development Table 86. BenevolentAI Company Information Table 87. BenevolentAI Business Overview Table 88. BenevolentAI AI-driven Peptide Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio Table 90. BenevolentAI Recent Development Table 91. Evotec Company Information Table 92. Evotec Business Overview Table 93. Evotec AI-driven Peptide Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio Table 95. Evotec Recent Development Table 96. PeptiFinder Company Information Table 97. PeptiFinder Business Overview Table 98. PeptiFinder AI-driven Peptide Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio Table 100. PeptiFinder Recent Development Table 101. Xtalpi Company Information Table 102. Xtalpi Business Overview Table 103. Xtalpi AI-driven Peptide Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio Table 105. Xtalpi Recent Development Table 106. Sun Novo Company Information Table 107. Sun Novo Business Overview Table 108. Sun Novo AI-driven Peptide Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio Table 110. Sun Novo Recent Development Table 111. Zonsen Peplib Biotech Company Information Table 112. Zonsen Peplib Biotech Business Overview Table 113. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 115. Zonsen Peplib Biotech Recent Development Table 116. Tide Tron Biotech Company Information Table 117. Tide Tron Biotech Business Overview Table 118. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio Table 120. Tide Tron Biotech Recent Development Table 121. North America AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 122. North America AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 123. North America AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 124. North America AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 125. North America AI-driven Peptide Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America AI-driven Peptide Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 127. North America AI-driven Peptide Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 128. Europe AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe AI-driven Peptide Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe AI-driven Peptide Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 134. Europe AI-driven Peptide Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 135. China AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 136. China AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 137. China AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 138. China AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 142. Asia AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 143. Asia AI-driven Peptide Drug Discovery Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia AI-driven Peptide Drug Discovery Platform Revenue by Region (US$ Million) & (2021-2026) Table 145. Asia AI-driven Peptide Drug Discovery Platform Revenue by Region (US$ Million) & (2027-2032) Table 146. SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026) & (US$ Million) Table 147. SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032) & (US$ Million) Table 148. SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026) & (US$ Million) Table 149. SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032) & (US$ Million) Table 150. SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Country (2021-2026) & (US$ Million) Table 152. SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Country (US$ Million) & (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. AI-driven Peptide Drug Discovery Platform Image Figure 2. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-driven Peptide Drug Discovery Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Design and Generation Platform Image Figure 5. Screening and Optimization Platform Image Figure 6. Data-driven Platform Image Figure 7. Others Image Figure 8. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global AI-driven Peptide Drug Discovery Platform Market Size Share 2021 VS 2025 VS 2032 Figure 10. Scientific Research Image Figure 11. Pharmaceuticals Image Figure 12. Global AI-driven Peptide Drug Discovery Platform Market Size (US$ Million) & (2021-2032) Figure 13. Global AI-driven Peptide Drug Discovery Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global AI-driven Peptide Drug Discovery Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global AI-driven Peptide Drug Discovery Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2021-2032) Figure 20. Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021-2032) Figure 23. North America AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 25. North America AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 26. North America AI-driven Peptide Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 27. United States AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 32. Europe AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 33. Europe AI-driven Peptide Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 34. Germany AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 44. China AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 45. Asia AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 47. Asia AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 48. Asia AI-driven Peptide Drug Discovery Platform Revenue Share by Region (2021-2032) Figure 49. Japan AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032) Figure 57. SAMEA AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032) Figure 58. SAMEA AI-driven Peptide Drug Discovery Platform Revenue Share by Country (2021-2032) Figure 59. Brazil AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt AI-driven Peptide Drug Discovery Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Design and Generation Platform
  • Screening and Optimization Platform
  • Data-driven Platform
  • Others
Applications
  • Scientific Research
  • Pharmaceuticals
Companies covered
  • Peptilogics
  • Pepticom Ltd
  • Menten AI
  • GUBRA
  • Creative Peptides
  • Exscalate
  • Generate Biomedicines
  • Receptor.AI
  • Insilico Medicine
  • Schrödinger
  • BenevolentAI
  • Evotec
  • PeptiFinder
  • Xtalpi
  • Sun Novo
  • Zonsen Peplib Biotech
  • Tide Tron Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 AI-driven Peptide Drug Discovery Platform Market by Type
  3. 1.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Design and Generation Platform
  5. 1.2.3 Screening and Optimization Platform
  6. 1.2.4 Data-driven Platform
  7. 1.2.5 Others
  8. 1.3 AI-driven Peptide Drug Discovery Platform Market by Application
  9. 1.3.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Scientific Research
  11. 1.3.3 Pharmaceuticals
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 AI-driven Peptide Drug Discovery Platform Market Dynamics
  1. 2.1 AI-driven Peptide Drug Discovery Platform Industry Trends
  2. 2.2 AI-driven Peptide Drug Discovery Platform Industry Drivers
  3. 2.3 AI-driven Peptide Drug Discovery Platform Industry Opportunities and Challenges
  4. 2.4 AI-driven Peptide Drug Discovery Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global AI-driven Peptide Drug Discovery Platform Market Perspective (2021-2032)
  2. 3.2 Global AI-driven Peptide Drug Discovery Platform Growth Trends by Region
  3. 3.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global AI-driven Peptide Drug Discovery Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Players
  2. 4.1.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global AI-driven Peptide Drug Discovery Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global AI-driven Peptide Drug Discovery Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global AI-driven Peptide Drug Discovery Platform Key Players Headquarters & Area Served
  7. 4.4 Global AI-driven Peptide Drug Discovery Platform Players, Product Type & Application
  8. 4.5 Global AI-driven Peptide Drug Discovery Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global AI-driven Peptide Drug Discovery Platform Market CR5 and HHI
  11. 4.6.3 2025 AI-driven Peptide Drug Discovery Platform Tier 1, Tier 2, and Tier 3
5 AI-driven Peptide Drug Discovery Platform Market Size by Type
  1. 5.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2032)
  3. 5.3 Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2021-2032)
6 AI-driven Peptide Drug Discovery Platform Market Size by Application
  1. 6.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2032)
  3. 6.3 Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Peptilogics
  2. 7.1.1 Peptilogics Company Information
  3. 7.1.2 Peptilogics Business Overview
  4. 7.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Product Portfolio
  6. 7.1.5 Peptilogics Recent Developments
  7. 7.2 Pepticom Ltd
  8. 7.2.1 Pepticom Ltd Company Information
  9. 7.2.2 Pepticom Ltd Business Overview
  10. 7.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Portfolio
  12. 7.2.5 Pepticom Ltd Recent Developments
  13. 7.3 Menten AI
  14. 7.3.1 Menten AI Company Information
  15. 7.3.2 Menten AI Business Overview
  16. 7.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  18. 7.3.5 Menten AI Recent Developments
  19. 7.4 GUBRA
  20. 7.4.1 GUBRA Company Information
  21. 7.4.2 GUBRA Business Overview
  22. 7.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Product Portfolio
  24. 7.4.5 GUBRA Recent Developments
  25. 7.5 Creative Peptides
  26. 7.5.1 Creative Peptides Company Information
  27. 7.5.2 Creative Peptides Business Overview
  28. 7.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Portfolio
  30. 7.5.5 Creative Peptides Recent Developments
  31. 7.6 Exscalate
  32. 7.6.1 Exscalate Company Information
  33. 7.6.2 Exscalate Business Overview
  34. 7.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Product Portfolio
  36. 7.6.5 Exscalate Recent Developments
  37. 7.7 Generate Biomedicines
  38. 7.7.1 Generate Biomedicines Company Information
  39. 7.7.2 Generate Biomedicines Business Overview
  40. 7.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Portfolio
  42. 7.7.5 Generate Biomedicines Recent Developments
  43. 7.8 Receptor.AI
  44. 7.8.1 Receptor.AI Company Information
  45. 7.8.2 Receptor.AI Business Overview
  46. 7.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Portfolio
  48. 7.8.5 Receptor.AI Recent Developments
  49. 7.9 Insilico Medicine
  50. 7.9.1 Insilico Medicine Company Information
  51. 7.9.2 Insilico Medicine Business Overview
  52. 7.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Portfolio
  54. 7.9.5 Insilico Medicine Recent Developments
  55. 7.10 Schrödinger
  56. 7.10.1 Schrödinger Company Information
  57. 7.10.2 Schrödinger Business Overview
  58. 7.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Product Portfolio
  60. 7.10.5 Schrödinger Recent Developments
  61. 7.11 BenevolentAI
  62. 7.11.1 BenevolentAI Company Information
  63. 7.11.2 BenevolentAI Business Overview
  64. 7.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Portfolio
  66. 7.11.5 BenevolentAI Recent Developments
  67. 7.12 Evotec
  68. 7.12.1 Evotec Company Information
  69. 7.12.2 Evotec Business Overview
  70. 7.12.3 Evotec AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Evotec AI-driven Peptide Drug Discovery Platform Product Portfolio
  72. 7.12.5 Evotec Recent Developments
  73. 7.13 PeptiFinder
  74. 7.13.1 PeptiFinder Company Information
  75. 7.13.2 PeptiFinder Business Overview
  76. 7.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Portfolio
  78. 7.13.5 PeptiFinder Recent Developments
  79. 7.14 Xtalpi
  80. 7.14.1 Xtalpi Company Information
  81. 7.14.2 Xtalpi Business Overview
  82. 7.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Product Portfolio
  84. 7.14.5 Xtalpi Recent Developments
  85. 7.15 Sun Novo
  86. 7.15.1 Sun Novo Company Information
  87. 7.15.2 Sun Novo Business Overview
  88. 7.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Product Portfolio
  90. 7.15.5 Sun Novo Recent Developments
  91. 7.16 Zonsen Peplib Biotech
  92. 7.16.1 Zonsen Peplib Biotech Company Information
  93. 7.16.2 Zonsen Peplib Biotech Business Overview
  94. 7.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  96. 7.16.5 Zonsen Peplib Biotech Recent Developments
  97. 7.17 Tide Tron Biotech
  98. 7.17.1 Tide Tron Biotech Company Information
  99. 7.17.2 Tide Tron Biotech Business Overview
  100. 7.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Portfolio
  102. 7.17.5 Tide Tron Biotech Recent Developments
8 North America
  1. 8.1 North America AI-driven Peptide Drug Discovery Platform Revenue (2021-2032)
  2. 8.2 North America AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032)
  5. 8.3 North America AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032)
  9. 8.5 North America AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America AI-driven Peptide Drug Discovery Platform Revenue by Country
  11. 8.6.1 North America AI-driven Peptide Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America AI-driven Peptide Drug Discovery Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America AI-driven Peptide Drug Discovery Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe AI-driven Peptide Drug Discovery Platform Revenue (2021-2032)
  2. 9.2 Europe AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032)
  5. 9.3 Europe AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032)
  9. 9.5 Europe AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe AI-driven Peptide Drug Discovery Platform Revenue by Country
  11. 9.6.1 Europe AI-driven Peptide Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe AI-driven Peptide Drug Discovery Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe AI-driven Peptide Drug Discovery Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China AI-driven Peptide Drug Discovery Platform Revenue (2021-2032)
  2. 10.2 China AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2032)
  3. 10.2.1 China AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026)
  4. 10.2.2 China AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032)
  5. 10.3 China AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 10.4 China AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2032)
  7. 10.4.1 China AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026)
  8. 10.4.2 China AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032)
  9. 10.5 China AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia AI-driven Peptide Drug Discovery Platform Revenue (2021-2032)
  2. 11.2 Asia AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032)
  5. 11.3 Asia AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032)
  9. 11.5 Asia AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia AI-driven Peptide Drug Discovery Platform Revenue by Country
  11. 11.6.1 Asia AI-driven Peptide Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia AI-driven Peptide Drug Discovery Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia AI-driven Peptide Drug Discovery Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA AI-driven Peptide Drug Discovery Platform Revenue (2021-2032)
  2. 12.2 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA AI-driven Peptide Drug Discovery Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA AI-driven Peptide Drug Discovery Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Country
  11. 12.6.1 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA AI-driven Peptide Drug Discovery Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst